Yeast Infection Diagnostics Market Outlook (2023 to 2033)

The yeast infection diagnostics market size is projected to be worth US$ 417.7 Million in 2023. The market is likely to surpass US$ 711.4 Million by 2033 at a CAGR of 5.5% during the forecast period. Growing yeast infection incidences is aiding the market growth. When the vagina is infected with Candida, it is referred to as a yeast infection. Candida is a kind of yeast. Candidiasis is most typically seen as a secondary illness in immunocompromised people. These are frequent dwellers in the mouth cavity, gastrointestinal tract, vagina, penis, and other areas. They only become pathogenic when favorable conditions exist. It can affect the mouth, vagina, penis, and other areas of the body. Antibiotic use is frequently linked to candidiasis. Cancer cytotoxic treatment can produce Candida albicans fungemia, which develops from fungal translocation across damaged mucosal barriers. Candidiasis is more common in old age and infants, according to NIH: StatPearls 2023. Yeast infection affects around 37% of newly born newborns in the United States.

Other Drivers Propelling the Demand for Yeast Infection Diagnostics Market include:

  • When natural immunity in the body is disrupted, yeast infection occurs. Covid infection has weakened immunity of whole world, making maximum world population susceptible to yeast infection.
  • Candida enters the bloodstream through three primary routes: the gastrointestinal tract mucosal barrier, an intravascular catheter, and a localized infection.
  • Candida can enter the circulation of both neutropenic and critical care unit patients. Yeast also constitute a typical part of the intestinal microbiota, and any disease that makes an individual immunocompromised might result in systemic candidiasis.
  • Yeast growth in catheters that are embedded, especially those with central lines, may occur regardless of the location of implantation or the hub, leading to a subsequent yeast infection.
  • Most businesses aspire to develop methods for managing bioinformatics processes using Graphical User Interfaces (GUIs), enabling non-skilled laboratory personnel or researchers to swiftly and efficiently analyze -omics data and deliver clearly interpretable findings.

Challenges for Companies /Manufacturers in the Yeast Infection Diagnostics Market:

  • Due to wide range of yeast being able to infect human, the challenge is to determine the causal agent precisely and quickly since this typically directs the right antifungal therapy.
  • The use of fungal-omics in detection remains a challenge. -Omics technologies create massive volumes of data, and most centers lack robust computer resources for data processing and storage.
  • Molecular approaches to improve yeast infection detection remains confined to a few specialized institutes.
  • While the introduction of commercial testing will stimulate wider application, more validation and cost reductions are necessary.

Opportunities in the Yeast Infection Diagnostics Market Industry:

  • Next-generation sequencing will offer valuable information on the mycobiome, antifungal resistance mechanisms, as well as broad-range diagnosis straight from the material, which might be crucial for the molecular identification of yeasts beyond Candida species.
  • With technology advancements, frontline laboratories want speedy, low-cost, reliable, and simple-to-implement assays to enhance yeast diagnosis. New technologies and diagnostic techniques based on microfluidics, optics, and nanotechnology are currently on their way.

Latest Trends in the Yeast Infection Diagnostics Market:

  • The purpose of yeast infection diagnostics is to produce point-of-care testing, which has become a trend in diagnostics, including fungal illnesses. The discipline of fungal infection diagnostics is beginning to capitalize on recent advances in fields like as proteomics and high-throughput generation sequencing.
  • Nonetheless, the major businesses and technology developers have seen the clinical sector's enormous potential and are working to build smaller, simpler, and less expensive equipment.
  • The introduction of palm-sized sequencing machines onto the market, as well as a growing range of point-of-care testing equipment, presages a technical revolution in diagnostic instruments commercially available to healthcare practitioners.
  • The rapid and reliable detection of a little amount of infectious agent remains the primary goal of yeast infection diagnostics. The gadget must also give other pertinent information, such as potential antifungal resistance and illness mode or stage detection.
Attributes Details
Yeast Infection Diagnostics Market Size (2023) US$ 417.7 Million
Yeast Infection Diagnostics Market Projected Size (2033) US$ 711.4 Million
Value CAGR (2023 to 2033) 5.5%

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

2012 to 2022 Yeast Infection Diagnostics Market Demand Outlook Compared to 2023 to 2033 Forecast

From 2012 to 2022, the global yeast infection diagnostics market experienced a CAGR of 4.4%, reaching a market size of US$ 417.7 Million in 2023.

From 2012 to 2022, the global yeast infection diagnostics market industry witnessed steady growth due to the increased prevalence of yeast infection. According to COVID-19, fungal infections can cause serious disease and death. COVID-19 with a fungal infection can coexist in some people. COVID-19 therapies, such as steroids and other medicines, can reduce the body's ability to fight fungus.

The creation of diagnostic kits has been facilitated by advances in genomic research and understanding of the genetic underpinnings of yeast specific biomarker.

Future Forecast for Yeast Infection Diagnostics Market Industry:

Looking ahead, the global Yeast Infection Diagnostics Market industry is expected to rise at a CAGR of 5.5% from 2023 to 2033. During the forecast period, the market size is expected to reach US$ 711.4 Million by 2033.

The yeast infection diagnostics market industry is expected to continue its growth trajectory from 2023 to 2033. Next generation sequencing has made diagnosis of causal species easy, with intervention of other detection techniques and artificial intelligence. Diagnosis process is prone to become easy, rapid and in small point-of-care testing.

Early identification and diagnosis of yeast infection improves patient health outcomes significantly. Yeast infection diagnostics offer the ability to detect infection and type of causal agent in early-stage of infection, allowing for earlier intervention and better survival rates. The emphasis on early diagnosis is anticipated to drive future demand for yeast infection diagnostic market.

Comparative View of the Yeast Infection Diagnostics Market

Yeast Infection Diagnostics Market:

Attributes Yeast Infection Diagnostics Market
CAGR (2023 to 2033) 5.5%
Market Value (2033) US$ 711.4 Million
Opportunity The increasing prevalence of yeast infection creates a huge market potential for yeast infection diagnosis equipment
Key Trends Advances in next generation sequencing, development of compact and accurate diagnostic equipment’s with bioinformatics intervention is key trend for this market.

Infection Prevention Market Outlook:

Attributes Infection Prevention Market Outlook
CAGR (2023 to 2033) 4.0%
Market Value (2033) US$ 60.6 Billion
Opportunity Adoption of plastic surgery and liposuction
Key Trends Surging government investments.

Uncomplicated Urinary Tract Infection Treatment Market:

Attributes Uncomplicated Urinary Tract Infection Treatment Market
CAGR (2023 to 2033) 10.0%
Market Value (2033) US$ 17 Billion
Opportunity UTIs are common medical condition, high prevalence of UTIs drive demand for UTI treatment product and services.
Key Trends The aging population is more susceptible to UTIs due to weakened immune systems and other factors and this demographic trend is expected to drive the growth of UTI treatment market.
Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Country-Wise Insights

Yeast Infection Diagnostics Market to Surge in the United States Due to Rising Prevalence of Yeast Infection.

Country The United States
Market Size (US$ Million) by End of Forecast Period (2033) US$ 204.9 Million
CAGR % 2023 to End of Forecast (2033) 4.5%

The Yeast Infection Diagnostics Market industry in the United States is expected to reach a market size of US$ 204.9 Million by 2033, expanding at a CAGR of 4.5%. Vaginal candidiasis is the most prevalent among all the yeast infections, according to the Centers for Disease Control and Prevention 2022. It is considered to be the second most prevalent kind of vaginal infection in the USA, following bacterial vaginal infections. Annually, around 1.4 million outpatient consultations for vaginal candidiasis are made.

Rising Demand for Yeast Infection Diagnostics Market is Due to the Growing Increasing Awareness and Screening Programs.

Country The United Kingdom
Market Size (US$ Million) by End of Forecast Period (2033) US$ 51.6 million
CAGR % 2023 to End of Forecast (2033) 3.7%

The yeast infection diagnostics market industry in the United Kingdom is expected to reach a market value of US$ 51.6 Million, expanding at a CAGR of 3.7% during the forecast period. According to the 2013 Health Technology Assessment, Candida albicans represented 61% of all Invasive fungal disease. According to an article provided by Public Health England 2021, the overall incidence of Candidaemia in England was 3.5 every 100,000 inhabitants in 2020, a modest rise from 2019 (3.1 per 100,000), with older people having the most severe prevalence of Candidaemia.

The rise in frequency between 2019 to 2020 might be attributed to a significant rise in the number of patients referred to intensive care units (ICUs) in the year 2020 as an outcome of the COVID-19 pandemic. Patients in ICUs are more likely to develop Candidaemia because the environment permits the opportunistic pathogen to grow invasive, and multiple risk factors underlying Candidaemia overlap with features of ICU patients. The present epidemiologic demographics of IFD in UK critical care units is described in the aforementioned paragraph.

Notable Growth Expected in China's Yeast Infection Diagnostics Market as Increasing commercial intervention to manufacture diagnostic kits.

Country China
Market Size (US$ Million) by End of Forecast Period (2033) US$ 64.8 million
CAGR % 2023 to End of Forecast (2033) 6.8%

The yeast infection diagnostics market industry in China is anticipated to reach a market size of US$ 64.8 million, moving at a CAGR of 6.8% during the forecast period. The yeast infection diagnostics market industry in China is expected to grow prominently due to the increasing commercial intervention in production of rapid diagnostic kits and real time PCR kits. As per The Lancet Infectious Diseases today 2018, Chinese, women are the world’s most numerous sufferers of thrush at 29.1 million.

Urn shaped demographics to Drive Market Growth in Japan

Country Japan
Market Size (US$ Million) by End of Forecast Period (2033) US$ 48.2 million
CAGR % 2023 to End of Forecast (2033) 6.4%

The yeast infection diagnostics market industry in Japan is estimated to reach a market size of US$ 48.2 million by 2033, thriving at a CAGR of 6.4%. When pre-reproductive and reproductive population are nearly comparable in quantity or proportion, and post-reproductive population have very few, bell-shaped age pyramids arise. Japanese demography reflects a curve with a bell shape, indicating that Japan has a larger elderly population. According to Geriatrics (Basel) 2020, there is an elevated prevalence of oral Candidiasis diagnosis in reliant Japanese elderly people. When contrasted with independent older adults, dependent seniors might be more prone to oral Candida albicans infection. As a result, Japan has emerged as a key market for yeast infection diagnostics.

Demand for Yeast Infection Diagnostics Market is Rising Due to Increasing Technological Advancements.

Country South Korea
Market Size (US$ Million) by End of Forecast Period (2033) US$ 5.1 Million
CAGR % 2023 to End of Forecast (2033) 8.2%

The yeast infection diagnostics market industry in South Korea is expected to reach a market size of US$ 5.1 million, expanding at a CAGR of 8.2% during the forecast period. South Korea is well-known for its technology breakthroughs and healthcare innovation. The country's strong emphasis on research and development, along with a favorable regulatory framework, leads to the growth of the yeast infection diagnostics market by allowing the development and commercialization of improved diagnostic technologies.

Category-Wise Insights

Strips to Dominate Therapeutic Area in Yeast Infection Diagnostics Market Industry with 60.2% Market Share in 2022

The test strips are predominant in yeast infection diagnostics market industry with a market share of 60.2% in 2022. Antifungal susceptibility testing (AFST) is currently frequently utilized and recommended in the treatment of patients suffering from persistent fungal infections like candidiasis and aspergillosis. The average vaginal pH ranges from 3.8 to 5.0. During a vaginal infection, the pH rises to 5.0-5.5 or 6.0-7.5, and vulvovaginal candidiasis is responsible for 20% to 25% of all vaginitis cases. The test strip is used to detect changes in vaginal pH; it is a tiny, paper-like strip that is put into the vagina for a few seconds before being compared to a color chart to ascertain the pH level.

Why Vaginal pH test is more prominent type of diagnostic in Yeast Infection Diagnostic Market

The vaginal pH Test constitutes 61.9% market share globally in 2022. Vaginal pH strip is more prominently used as it is easy to use by the patients. The strip is cost effective with comparison to the other diagnostic kits. It is more convenient and non-invasive method for initial screening of yeast infection.

Which End User Is Widely Adopted In the Market?

The Hospitals are dominating the yeast infection diagnostics market with the market share of 39.2% in 2022. A hospital is able to cut expenses by offering a complete range of services to patients. Doctors can utilize a variety of diagnostic tests to determine the source of a patient's symptoms. A commitment to provide high-quality care at a reasonable cost. A hospital can assist in identifying potential issues early on, before they become more serious. It enables rapid intervention and therapy, which improves the results for patients.

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

How Key Players Stay Competitive in the Yeast Infection Diagnostics Market Industry?

The market for yeast infection diagnostics is very competitive, with numerous businesses vying for market supremacy. In order to remain a step ahead of the competition in a scenario like this, major players have to implement smart strategies.

Key Strategies Used by the Participants

  • Product Innovation

Key players focus on developing and introducing innovative products to address unmet needs in the market. They invest in research and development to improve existing formulations, delivery systems, and enhance the efficacy and safety of the products

  • Strategic Partnerships and Collaborations

Key players often form strategic partnerships and collaborations with other companies, research institutes, or healthcare organizations, these partnerships allow for knowledge sharing, joint research and development efforts, and access to complementary technologies or expertise.

  • Expansion into Emerging Markets

Key players strive to expand their presence in different geographic regions to tap into new markets and reach a wider customer base. They may establish subsidiaries, distribution networks. Or strategic alliances in various countries to strengthen their market position.

  • Mergers and Acquisitions

Companies in the market may engage in mergers or acquisitions to consolidate their product portfolio, acquire new technologies, these strategic moves allow companies to enter new market segments, gain access to novel products or intellectual property, and achieve synergies in terms of research, manufacturing, or distributions.

Key Players in the Yeast Infection Diagnostics Market Industry

  • Hologic Inc.
  • Becton, Dickinson and Company
  • Natureland Health
  • Stix's
  • PGYARD
  • myLAB Box
  • Juno Bio
  • Seroflora
  • PrivaPath Diagnostics
  • NutraBlast
  • Rite Aid Corporation
  • Home Health (UK) Ltd
  • Loyalbody
  • Savyon Diagnostics
  • BIOSYNEX SA
  • Quantbiome, Inc.

Key Developments in the Yeast Infection Diagnostics Market:

  • In March, 2023, The FDA granted Becton Dickinson 510(k) authorization for their Vaginal Panel test using the COR platform. The organization's high-throughput molecular testing technology for commercial laboratories is called BD COR.
  • On July, 2021, Savyon Diagnostics created the SavvyCheck Vaginal Yeast Test, which is part of a large-scale, multi-site clinical investigation being undertaken at military medical centres and headquarters across the United States.

Segmentation Analysis of the Yeast Infection Diagnostics Market

By Product:

  • Strips
  • Cassettes
  • Panel Test

By Test Type:

  • Vaginal pH Test
  • Nucleic Acid Amplification Testing (NAAT)
  • Microbiome Test

By Body Part:

  • Vagina
  • Penis
  • Mouth
  • Nail
  • Skin folds

By Indication:

  • Vulvovaginal Candidiasis
  • Trichomoniasis
  • Chlamydia
  • Gonorrhea
  • Bacterial Vaginosis
  • Others

By End User:

  • Hospitals
  • Diagnostics Laboratories
  • Specialty Clinics
  • Homecare Settings

By Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • The Middle East & Africa

Frequently Asked Questions

What is Driving Demand in South Korea?

An increase in technological advancements drives the demand.

What Drives Sales of the Market?

The rapid and reliable detection of a small number of infectious agents drives sales.

What is the Growth Forecast for the Yeast Infection Diagnostics Market in 2023?

The market expands at a CAGR of 5.5% from 2023 to 2033.

How will China Offer Lucrative Growth Opportunities?

The increase in commercial intervention in the production of rapid diagnostic kits raises the demand in China.

What is China’s Market Growth Outlook?

China is likely to expand at a CAGR of 6.8% from 2023 to 2033.

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand Side Trends

    1.3. Supply Side Trends

    1.4. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

    2.3. Inclusions and Exclusions

3. Key Market Trends

    3.1. Key Trends Impacting the Market

    3.2. Product Innovation / Development Trends

4. Value Added Insights

    4.1. Product Adoption / Usage Analysis

    4.2. Recent Product Approvals/Launches

    4.3. Regulatory Landscape

    4.4. Statistics of Yeast infection & Treatment Procedures

    4.5. PESTEL Analysis

    4.6. Porter’s Analysis

    4.7. Unmet Needs for Diagnostic Kits

5. Market Background

    5.1. Macro-Economic Factors

        5.1.1. Global Healthcare Expenditure Outlook

        5.1.2. Global Medical Device Outlook

        5.1.3. Global Life Expectancy Outlook

    5.2. Forecast Factors - Relevance & Impact

        5.2.1. Key Player’s Historic Growth

        5.2.2. Growing Awareness about Cancer Diseases

        5.2.3. Favourable Government Regulations

        5.2.4. Rising Demand for Minimally Invasive Procedures

        5.2.5. Technological Advancement in the Devices

        5.2.6. Increasing Prevalence of Yeast Infection

    5.3. Dynamics

        5.3.1. Drivers

        5.3.2. Restraints

        5.3.3. Opportunity Analysis

6. Global Market Volume (in Units) Analysis 2012 to 2022 and Forecast, 2023 to 2033

    6.1. Historical Volume (in Units) Analysis, 2012 to 2022

    6.2. Current and Future Volume (in Units) Projections, 2023 to 2033

        6.2.1. Y-o-Y Growth Trend Analysis

7. Global Market - Pricing Analysis

    7.1. Regional Pricing Analysis By Product

    7.2. Pricing Break-up

        7.2.1. Manufacturer Level Pricing

        7.2.2. Distributor Level Pricing

    7.3. Global Average Pricing Analysis Benchmark

    7.4. Pricing Assumptions

8. Global Market Demand (in Value or Size in US$ Mn) Analysis 2012 to 2022 and Forecast, 2023 to 2033

    8.1. Historical Market Value (US$ Million) Analysis, 2012 to 2022

    8.2. Current and Future Market Value (US$ Million) Projections, 2023 to 2033

        8.2.1. Y-o-Y Growth Trend Analysis

        8.2.2. Absolute $ Opportunity Analysis

9. Global Market Analysis 2012 to 2022 and Forecast 2023 to 2033, By Product

    9.1. Introduction / Key Findings

    9.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Product, 2012 to 2022

    9.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Product, 2023 to 2033

        9.3.1. Strips

        9.3.2. Cassettes

        9.3.3. Panel Test

    9.4. Market Attractiveness Analysis By Product

10. Global Market Analysis 2012 to 2022 and Forecast 2023 to 2033, By Test Type

    10.1. Introduction / Key Findings

    10.2. Historical Market Size (US$ Million) Analysis By Test Type, 2012 to 2022

    10.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Test Type, 2023 to 2033

        10.3.1. Vaginal pH Test

        10.3.2. Nucleic Acid Amplification Testing (NAAT)

        10.3.3. Microbiome Test

    10.4. Market Attractiveness Analysis By Test Type

11. Global Market Analysis 2012 to 2022 and Forecast 2023 to 2033, By Body Part

    11.1. Introduction / Key Findings

    11.2. Historical Market Size (US$ Million) Analysis By Body Part, 2012 to 2022

    11.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Body Part, 2023 to 2033

        11.3.1. Vagina

        11.3.2. Penis

        11.3.3. Mouth

        11.3.4. Nail

        11.3.5. Skin folds

    11.4. Market Attractiveness Analysis By Body Part

12. Global Market Analysis 2012 to 2022 and Forecast 2023 to 2033, By Indication

    12.1. Introduction / Key Findings

    12.2. Historical Market Size (US$ Million) Analysis By Indication, 2012 to 2022

    12.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Indication, 2023 to 2033

        12.3.1. Vulvovaginal Candidiasis

        12.3.2. Trichomoniasis

        12.3.3. Chlamydia

        12.3.4. Gonorrhea

        12.3.5. Bacterial Vaginosis

    12.4. Market Attractiveness Analysis By Indication

13. Global Market Analysis 2012 to 2022 and Forecast 2023 to 2033, By End User

    13.1. Introduction / Key Findings

    13.2. Historical Market Size (US$ Million) Analysis By End User, 2012 to 2022

    13.3. Current and Future Market Size (US$ Million) Analysis and Forecast By End User, 2023 to 2033

        13.3.1. Hospitals

        13.3.2. Diagnostic Laboratories

        13.3.3. Specialty Clinics

        13.3.4. Homecare Settings

    13.4. Market Attractiveness Analysis By End User

14. Global Market Analysis 2012 to 2022 and Forecast 2023 to 2033, by Region

    14.1. Introduction

    14.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Region, 2012 to 2022

    14.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Region, 2023 to 2033

        14.3.1. North America

        14.3.2. Latin America

        14.3.3. Europe

        14.3.4. South Asia

        14.3.5. East Asia

        14.3.6. Oceania

        14.3.7. Middle East and Africa (MEA)

    14.4. Market Attractiveness Analysis By Region

15. North America Market Analysis 2012 to 2022 and Forecast 2023 to 2033

    15.1. Introduction

    15.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2012 to 2022

    15.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033

        15.3.1. By Country

            15.3.1.1. USA

            15.3.1.2. Canada

        15.3.2. By Product

        15.3.3. By Test Type

        15.3.4. By Body Part

        15.3.5. By Indication

        15.3.6. By End User

    15.4. Market Attractiveness Analysis

        15.4.1. By Country

        15.4.2. By Product

        15.4.3. By Test Type

        15.4.4. By Body Part

        15.4.5. By Indication

        15.4.6. By End User

    15.5. Country Level Analysis & Forecast

        15.5.1. USA Market Analysis

            15.5.1.1. .Introduction

            15.5.1.2. Market Analysis and Forecast by Market Taxonomy

                15.5.1.2.1. By Product

                15.5.1.2.2. By Test Type

                15.5.1.2.3. By Body Part

                15.5.1.2.4. By Indication

                15.5.1.2.5. By End User

        15.5.2. Canada Market Analysis

            15.5.2.1. Introduction

            15.5.2.2. Market Analysis and Forecast by Market Taxonomy

                15.5.2.2.1. By Product

                15.5.2.2.2. By Test Type

                15.5.2.2.3. By Body Part

                15.5.2.2.4. By Indication

                15.5.2.2.5. By End User

    15.6. Market Trends

    15.7. Key Market Participants - Intensity Mapping

    15.8. Drivers and Restraints - Impact Analysis

16. Latin America Market Analysis 2012 to 2022 and Forecast 2023 to 2033

    16.1. Introduction

    16.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2012 to 2022

    16.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033

        16.3.1. By Country

            16.3.1.1. Brazil

            16.3.1.2. Mexico

            16.3.1.3. Argentina

            16.3.1.4. Rest of Latin America

        16.3.2. By Product

        16.3.3. By Test Type

        16.3.4. By Body Part

        16.3.5. By Indication

        16.3.6. By End User

    16.4. Market Attractiveness Analysis

        16.4.1. By Country

        16.4.2. By Product

        16.4.3. By Test Type

        16.4.4. By Body Part

        16.4.5. By Indication

        16.4.6. By End User

    16.5. Country Level Analysis & Forecast

        16.5.1. Brazil Market Analysis

            16.5.1.1. .Introduction

            16.5.1.2. Market Analysis and Forecast by Market Taxonomy

                16.5.1.2.1. By Product

                16.5.1.2.2. By Test Type

                16.5.1.2.3. By Body Part

                16.5.1.2.4. By Indication

                16.5.1.2.5. By End User

        16.5.2. Mexico Market Analysis

            16.5.2.1. Introduction

            16.5.2.2. Market Analysis and Forecast by Market Taxonomy

                16.5.2.2.1. By Product

                16.5.2.2.2. By Test Type

                16.5.2.2.3. By Body Part

                16.5.2.2.4. By Indication

                16.5.2.2.5. By End User

        16.5.3. Argentina Market Analysis

            16.5.3.1. Introduction

            16.5.3.2. Market Analysis and Forecast by Market Taxonomy

                16.5.3.2.1. By Product

                16.5.3.2.2. By Test Type

                16.5.3.2.3. By Body Part

                16.5.3.2.4. By Indication

                16.5.3.2.5. By End User

    16.6. Market Trends

    16.7. Key Market Participants - Intensity Mapping

    16.8. Drivers and Restraints - Impact Analysis

17. Europe Market Analysis 2012 to 2022 and Forecast 2023 to 2033

    17.1. Introduction

    17.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2012 to 2022

    17.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033

        17.3.1. By Country

            17.3.1.1. Germany

            17.3.1.2. France

            17.3.1.3. Italy

            17.3.1.4. UK

            17.3.1.5. Spain

            17.3.1.6. Russia

            17.3.1.7. BENELUX

            17.3.1.8. Rest of Europe

        17.3.2. By Product

        17.3.3. By Test Type

        17.3.4. By Body Part

        17.3.5. By Indication

        17.3.6. By End User

    17.4. Market Attractiveness Analysis

        17.4.1. By Country

        17.4.2. By Product

        17.4.3. By Test Type

        17.4.4. By Body Part

        17.4.5. By Indication

        17.4.6. By End User

    17.5. Country Level Analysis & Forecast

        17.5.1. Germany Market Analysis

            17.5.1.1. .Introduction

            17.5.1.2. Market Analysis and Forecast by Market Taxonomy

                17.5.1.2.1. By Product

                17.5.1.2.2. By Test Type

                17.5.1.2.3. By Body Part

                17.5.1.2.4. By Indication

                17.5.1.2.5. By End User

        17.5.2. France Market Analysis

            17.5.2.1. Introduction

            17.5.2.2. Market Analysis and Forecast by Market Taxonomy

                17.5.2.2.1. By Product

                17.5.2.2.2. By Test Type

                17.5.2.2.3. By Body Part

                17.5.2.2.4. By Indication

                17.5.2.2.5. By End User

        17.5.3. Italy Market Analysis

            17.5.3.1. Introduction

            17.5.3.2. Market Analysis and Forecast by Market Taxonomy

                17.5.3.2.1. By Product

                17.5.3.2.2. By Test Type

                17.5.3.2.3. By Body Part

                17.5.3.2.4. By Indication

                17.5.3.2.5. By End User

        17.5.4. UK Market Analysis

            17.5.4.1. .Introduction

            17.5.4.2. Market Analysis and Forecast by Market Taxonomy

                17.5.4.2.1. By Product

                17.5.4.2.2. By Test Type

                17.5.4.2.3. By Body Part

                17.5.4.2.4. By Indication

                17.5.4.2.5. By End User

        17.5.5. Spain Market Analysis

            17.5.5.1. .Introduction

            17.5.5.2. Market Analysis and Forecast by Market Taxonomy

                17.5.5.2.1. By Product

                17.5.5.2.2. By Test Type

                17.5.5.2.3. By Body Part

                17.5.5.2.4. By Indication

                17.5.5.2.5. By End User

        17.5.6. Russia Market Analysis

            17.5.6.1. .Introduction

            17.5.6.2. Market Analysis and Forecast by Market Taxonomy

                17.5.6.2.1. By Product

                17.5.6.2.2. By Test Type

                17.5.6.2.3. By Body Part

                17.5.6.2.4. By Indication

                17.5.6.2.5. By End User

        17.5.7. BENELUX Market Analysis

            17.5.7.1. .Introduction

            17.5.7.2. Market Analysis and Forecast by Market Taxonomy

                17.5.7.2.1. By Product

                17.5.7.2.2. By Test Type

                17.5.7.2.3. By Body Part

                17.5.7.2.4. By Indication

                17.5.7.2.5. By End User

    17.6. Market Trends

    17.7. Key Market Participants - Intensity Mapping

    17.8. Drivers and Restraints - Impact Analysis

18. South Asia Market Analysis 2012 to 2022 and Forecast 2023 to 2033

    18.1. Introduction

    18.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2012 to 2022

    18.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033

        18.3.1. By Country

            18.3.1.1. India

            18.3.1.2. Thailand

            18.3.1.3. Indonesia

            18.3.1.4. Malaysia

            18.3.1.5. Rest of South Asia

        18.3.2. By Product

        18.3.3. By Test Type

        18.3.4. By Body Part

        18.3.5. By Indication

        18.3.6. By End User

    18.4. Market Attractiveness Analysis

        18.4.1. By Country

        18.4.2. By Product

        18.4.3. By Test Type

        18.4.4. By Body Part

        18.4.5. By Indication

        18.4.6. By End User

    18.5. Country Level Analysis & Forecast

        18.5.1. India Market Analysis

            18.5.1.1. .Introduction

            18.5.1.2. Market Analysis and Forecast by Market Taxonomy

                18.5.1.2.1. By Product

                18.5.1.2.2. By Test Type

                18.5.1.2.3. By Body Part

                18.5.1.2.4. By Indication

                18.5.1.2.5. By End User

        18.5.2. Thailand Market Analysis

            18.5.2.1. .Introduction

            18.5.2.2. Market Analysis and Forecast by Market Taxonomy

                18.5.2.2.1. By Product

                18.5.2.2.2. By Test Type

                18.5.2.2.3. By Body Part

                18.5.2.2.4. By Indication

                18.5.2.2.5. By End User

        18.5.3. Indonesia Market Analysis

            18.5.3.1. Introduction

            18.5.3.2. Market Analysis and Forecast by Market Taxonomy

                18.5.3.2.1. By Product

                18.5.3.2.2. By Test Type

                18.5.3.2.3. By Body Part

                18.5.3.2.4. By Indication

                18.5.3.2.5. By End User

        18.5.4. Malaysia Market Analysis

            18.5.4.1. Introduction

            18.5.4.2. Market Analysis and Forecast by Market Taxonomy

                18.5.4.2.1. By Product

                18.5.4.2.2. By Test Type

                18.5.4.2.3. By Body Part

                18.5.4.2.4. By Indication

                18.5.4.2.5. By End User

    18.6. Market Trends

    18.7. Key Market Participants - Intensity Mapping

    18.8. Drivers and Restraints - Impact Analysis

19. East Asia Market Analysis 2012 to 2022 and Forecast 2023 to 2033

    19.1. Introduction

    19.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2012 to 2022

    19.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033

        19.3.1. By Country

            19.3.1.1. China

            19.3.1.2. Japan

            19.3.1.3. South Korea

        19.3.2. By Product

        19.3.3. By Test Type

        19.3.4. By Body Part

        19.3.5. By Indication

        19.3.6. By End User

    19.4. Market Attractiveness Analysis

        19.4.1. By Country

        19.4.2. By Product

        19.4.3. By Test Type

        19.4.4. By Body Part

        19.4.5. By Indication

        19.4.6. By End User

    19.5. Country Level Analysis & Forecast

        19.5.1. China Market Analysis

            19.5.1.1. .Introduction

            19.5.1.2. Market Analysis and Forecast by Market Taxonomy

                19.5.1.2.1. By Product

                19.5.1.2.2. By Test Type

                19.5.1.2.3. By Body Part

                19.5.1.2.4. By Indication

                19.5.1.2.5. By End User

        19.5.2. Japan Market Analysis

            19.5.2.1. Introduction

            19.5.2.2. Market Analysis and Forecast by Market Taxonomy

                19.5.2.2.1. By Product

                19.5.2.2.2. By Test Type

                19.5.2.2.3. By Body Part

                19.5.2.2.4. By Indication

                19.5.2.2.5. By End User

        19.5.3. South Korea Market Analysis

            19.5.3.1. Introduction

            19.5.3.2. Market Analysis and Forecast by Market Taxonomy

                19.5.3.2.1. By Product

                19.5.3.2.2. By Test Type

                19.5.3.2.3. By Body Part

                19.5.3.2.4. By Indication

                19.5.3.2.5. By End User

    19.6. Market Trends

    19.7. Key Market Participants - Intensity Mapping

    19.8. Drivers and Restraints - Impact Analysis

20. Oceania Market Analysis 2012 to 2022 and Forecast 2023 to 2033

    20.1. Introduction

    20.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2012 to 2022

    20.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033

        20.3.1. By Country

            20.3.1.1. Australia

            20.3.1.2. New Zealand

        20.3.2. By Product

        20.3.3. By Test Type

        20.3.4. By Body Part

        20.3.5. By Indication

        20.3.6. By End User

    20.4. Market Attractiveness Analysis

        20.4.1. By Country

        20.4.2. By Product

        20.4.3. By Test Type

        20.4.4. By Body Part

        20.4.5. By Indication

        20.4.6. By End User

    20.5. Country Level Analysis & Forecast

        20.5.1. Australia Market Analysis

            20.5.1.1. .Introduction

            20.5.1.2. Market Analysis and Forecast by Market Taxonomy

                20.5.1.2.1. By Product

                20.5.1.2.2. By Test Type

                20.5.1.2.3. By Body Part

                20.5.1.2.4. By Indication

                20.5.1.2.5. By End User

        20.5.2. New Zealand Market Analysis

            20.5.2.1. Introduction

            20.5.2.2. Market Analysis and Forecast by Market Taxonomy

                20.5.2.2.1. By Product

                20.5.2.2.2. By Test Type

                20.5.2.2.3. By Body Part

                20.5.2.2.4. By Indication

                20.5.2.2.5. By End User

    20.6. Market Trends

    20.7. Key Market Participants - Intensity Mapping

    20.8. Drivers and Restraints - Impact Analysis

21. Middle East and Africa Market Analysis 2012 to 2022 and Forecast 2023 to 2033

    21.1. Introduction

    21.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2012 to 2022

    21.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033

        21.3.1. By Country

            21.3.1.1. GCC Countries

            21.3.1.2. Türkiye

            21.3.1.3. Northern Africa

            21.3.1.4. South Africa

            21.3.1.5. Rest of Middle East and Africa

        21.3.2. By Product

        21.3.3. By Test Type

        21.3.4. By Body Part

        21.3.5. By Indication

        21.3.6. By End User

    21.4. Market Attractiveness Analysis

        21.4.1. By Country

        21.4.2. By Product

        21.4.3. By Test Type

        21.4.4. By Body Part

        21.4.5. By Indication

        21.4.6. By End User

    21.5. Country Level Analysis & Forecast

        21.5.1. GCC Countries Market Analysis

            21.5.1.1. .Introduction

            21.5.1.2. Market Analysis and Forecast by Market Taxonomy

                21.5.1.2.1. By Product

                21.5.1.2.2. By Test Type

                21.5.1.2.3. By Body Part

                21.5.1.2.4. By Indication

                21.5.1.2.5. By End User

        21.5.2. Türkiye Market Analysis

            21.5.2.1. Introduction

            21.5.2.2. Market Analysis and Forecast by Market Taxonomy

                21.5.2.2.1. By Product

                21.5.2.2.2. By Test Type

                21.5.2.2.3. By Body Part

                21.5.2.2.4. By Indication

                21.5.2.2.5. By End User

        21.5.3. Northern Africa Market Analysis

            21.5.3.1. Introduction

            21.5.3.2. Market Analysis and Forecast by Market Taxonomy

                21.5.3.2.1. By Product

                21.5.3.2.2. By Test Type

                21.5.3.2.3. By Body Part

                21.5.3.2.4. By Indication

                21.5.3.2.5. By End User

        21.5.4. South Africa Market Analysis

            21.5.4.1. Introduction

            21.5.4.2. Market Analysis and Forecast by Market Taxonomy

                21.5.4.2.1. By Product

                21.5.4.2.2. By Test Type

                21.5.4.2.3. By Body Part

                21.5.4.2.4. By Indication

                21.5.4.2.5. By End User

    21.6. Market Trends

    21.7. Key Market Participants - Intensity Mapping

    21.8. Drivers and Restraints - Impact Analysis

22. Market Structure Analysis

    22.1. Market Analysis by Tier of Companies

    22.2. Market Share Analysis of Top Players

    22.3. Market Presence Analysis

23. Competition Analysis

    23.1. Competition Dashboard

    23.2. Competition Benchmarking

    23.3. Competition Deep Dive

        23.3.1. Hologic Inc.

            23.3.1.1. Overview

            23.3.1.2. Product Portfolio

            23.3.1.3. Key Financials

            23.3.1.4. Sales Footprint

            23.3.1.5. SWOT Analysis

            23.3.1.6. Strategy Overview

                23.3.1.6.1. Marketing Strategy

                23.3.1.6.2. Product Strategy

                23.3.1.6.3. Channel Strategy

        23.3.2. Becton, Dickinson and Company

            23.3.2.1. Overview

            23.3.2.2. Product Portfolio

            23.3.2.3. Key Financials

            23.3.2.4. Sales Footprint

            23.3.2.5. SWOT Analysis

            23.3.2.6. Strategy Overview

                23.3.2.6.1. Marketing Strategy

                23.3.2.6.2. Product Strategy

                23.3.2.6.3. Channel Strategy

        23.3.3. Natureland Health

            23.3.3.1. Overview

            23.3.3.2. Product Portfolio

            23.3.3.3. Key Financials

            23.3.3.4. Sales Footprint

            23.3.3.5. SWOT Analysis

            23.3.3.6. Strategy Overview

                23.3.3.6.1. Marketing Strategy

                23.3.3.6.2. Product Strategy

                23.3.3.6.3. Channel Strategy

        23.3.4. Stix's

            23.3.4.1. Overview

            23.3.4.2. Product Portfolio

            23.3.4.3. Key Financials

            23.3.4.4. Sales Footprint

            23.3.4.5. SWOT Analysis

            23.3.4.6. Strategy Overview

                23.3.4.6.1. Marketing Strategy

                23.3.4.6.2. Product Strategy

                23.3.4.6.3. Channel Strategy

        23.3.5. PGYARD

            23.3.5.1. Overview

            23.3.5.2. Product Portfolio

            23.3.5.3. Key Financials

            23.3.5.4. Sales Footprint

            23.3.5.5. SWOT Analysis

            23.3.5.6. Strategy Overview

                23.3.5.6.1. Marketing Strategy

                23.3.5.6.2. Product Strategy

                23.3.5.6.3. Channel Strategy

        23.3.6. myLAB Box

            23.3.6.1. Overview

            23.3.6.2. Product Portfolio

            23.3.6.3. Key Financials

            23.3.6.4. Sales Footprint

            23.3.6.5. SWOT Analysis

            23.3.6.6. Strategy Overview

                23.3.6.6.1. Marketing Strategy

                23.3.6.6.2. Product Strategy

                23.3.6.6.3. Channel Strategy

        23.3.7. Juno Bio

            23.3.7.1. Overview

            23.3.7.2. Product Portfolio

            23.3.7.3. Key Financials

            23.3.7.4. Sales Footprint

            23.3.7.5. SWOT Analysis

            23.3.7.6. Strategy Overview

                23.3.7.6.1. Marketing Strategy

                23.3.7.6.2. Product Strategy

                23.3.7.6.3. Channel Strategy

        23.3.8. Seroflora

            23.3.8.1. Overview

            23.3.8.2. Product Portfolio

            23.3.8.3. Key Financials

            23.3.8.4. Sales Footprint

            23.3.8.5. SWOT Analysis

            23.3.8.6. Strategy Overview

                23.3.8.6.1. Marketing Strategy

                23.3.8.6.2. Product Strategy

                23.3.8.6.3. Channel Strategy

        23.3.9. PrivaPath Diagnostics

            23.3.9.1. Overview

            23.3.9.2. Product Portfolio

            23.3.9.3. Key Financials

            23.3.9.4. Sales Footprint

            23.3.9.5. SWOT Analysis

            23.3.9.6. Strategy Overview

                23.3.9.6.1. Marketing Strategy

                23.3.9.6.2. Product Strategy

                23.3.9.6.3. Channel Strategy

        23.3.10. NutraBlast

            23.3.10.1. Overview

            23.3.10.2. Product Portfolio

            23.3.10.3. Key Financials

            23.3.10.4. Sales Footprint

            23.3.10.5. SWOT Analysis

            23.3.10.6. Strategy Overview

                23.3.10.6.1. Marketing Strategy

                23.3.10.6.2. Product Strategy

                23.3.10.6.3. Channel Strategy

        23.3.11. Rite Aid Corporation

            23.3.11.1. Overview

            23.3.11.2. Product Portfolio

            23.3.11.3. Key Financials

            23.3.11.4. Sales Footprint

            23.3.11.5. SWOT Analysis

            23.3.11.6. Strategy Overview

                23.3.11.6.1. Marketing Strategy

                23.3.11.6.2. Product Strategy

                23.3.11.6.3. Channel Strategy

        23.3.12. Home Health (UK) Ltd

            23.3.12.1. Overview

            23.3.12.2. Product Portfolio

            23.3.12.3. Key Financials

            23.3.12.4. Sales Footprint

            23.3.12.5. SWOT Analysis

            23.3.12.6. Strategy Overview

                23.3.12.6.1. Marketing Strategy

                23.3.12.6.2. Product Strategy

                23.3.12.6.3. Channel Strategy

        23.3.13. Loyalbody

            23.3.13.1. Overview

            23.3.13.2. Product Portfolio

            23.3.13.3. Key Financials

            23.3.13.4. Sales Footprint

            23.3.13.5. SWOT Analysis

            23.3.13.6. Strategy Overview

                23.3.13.6.1. Marketing Strategy

                23.3.13.6.2. Product Strategy

                23.3.13.6.3. Channel Strategy

        23.3.14. Savyon Diagnostics

            23.3.14.1. Overview

            23.3.14.2. Product Portfolio

            23.3.14.3. Key Financials

            23.3.14.4. Sales Footprint

            23.3.14.5. SWOT Analysis

            23.3.14.6. Strategy Overview

                23.3.14.6.1. Marketing Strategy

                23.3.14.6.2. Product Strategy

                23.3.14.6.3. Channel Strategy

        23.3.15. BIOSYNEX SA

            23.3.15.1. Overview

            23.3.15.2. Product Portfolio

            23.3.15.3. Key Financials

            23.3.15.4. Sales Footprint

            23.3.15.5. SWOT Analysis

            23.3.15.6. Strategy Overview

                23.3.15.6.1. Marketing Strategy

                23.3.15.6.2. Product Strategy

                23.3.15.6.3. Channel Strategy

        23.3.16. Quantbiome, Inc.

            23.3.16.1. Overview

            23.3.16.2. Product Portfolio

            23.3.16.3. Key Financials

            23.3.16.4. Sales Footprint

            23.3.16.5. SWOT Analysis

            23.3.16.6. Strategy Overview

                23.3.16.6.1. Marketing Strategy

                23.3.16.6.2. Product Strategy

                23.3.16.6.3. Channel Strategy

24. Assumptions and Acronyms Used

25. Research Methodology

Explore Healthcare Insights

View Reports
Future Market Insights

Yeast Infection Diagnostics Market